Benzinga | May 6, 2021 05:34PM EDT

CytomX Therapeutics Q1 EPS $(0.26) Beats $(0.35) Estimate, Sales $15.97M Beat $15.43M Estimate

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.35) by 25.71 percent. This is a 200 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $15.97 million which beat the analyst consensus estimate of $15.43 million by 3.51 percent. This is a 67.80 percent decrease over sales of $49.59 million the same period last year.